Business ❯Pharmaceutical Industry ❯Drug Manufacturers ❯Novo Nordisk

Eli Lilly

Medicare Expands Drug Price Negotiations to Include Popular Weight-Loss Medications

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Biden Proposal for Medicare and Medicaid to Cover Weight-Loss Drugs Faces Uncertain Future Under Trump Administration